ライフサイエンスコーパス: visual acuity

1 coordinated movement of the eyeballs and for visual acuity.

2 nd glaucoma are factors associated with poor visual acuity.

3 a large European cohort with relatively good visual acuity.

4 ting, surgical technique, complications, and visual acuity.

5 ange, whereas 2 eyes (4.4%) had worsening of visual acuity.

6 ke patterning of the cone mosaic may improve visual acuity.

7 ablish thick myelination demanded for a keen visual acuity.

8 ents correlated with both radiation dose and visual acuity.

9 ppointment due to an asymmetric worsening of visual acuity.

10 hyperpermeability on ICGA and improvement of visual acuity.

11 direction beyond the efforts to improve the visual acuity.

12 tion with corneal shape parameters than with visual acuity.

13 redictor of perforation, scar size, or final visual acuity.

14 he reported AEs had no significant impact on visual acuity.

15 phs, optical coherence tomography (OCT), and visual acuity.

16 nverted ILM flaps repaired FTMH and improved visual acuity.

17 tween patient groups with different baseline visual acuities.

18 score, was calculated using recorded Snellen visual acuities.

19 icant difference was found in best-corrected visual acuity (0.01 logarithm of the minimum angle of re

20 logarithm of the minimum angle of resolution visual acuity (1.28 vs. 0.51, P < 0.001) (Snellen equiva

21 erall, 82.2% eyes (37/45) had improvement in visual acuity, 13.3% (6/45) experienced no change, where

22 ten times smaller and concordant with mouse visual acuity(15).

23 P = 0.03), with better median final Snellen visual acuity (20/30 vs. 20/70; not significant).

24 s and floaters (42.5%; n = 420), decrease in visual acuity (32.1%; n = 317), generalized eye pain (7.

25 idal melanoma with PDT effectively preserves visual acuity, 5-year treatment-success calculated by Ka

26 .4+/-94.6 mum, respectively, P = .066) or in visual acuity (66.5 +/- 14.3 and 68.9 +/- 14.5, respecti

27 lution of CME with concurrent improvement in visual acuity after an average of 6 weeks of therapy (ra

28 Visual acuity after bilateral cataract surgery in infant

29 Best-corrected visual acuity and central macular thickness were measure

30 story, and ocular medical history, including visual acuity and central retinal thicknesses, were exam

31 corneal apex had stronger correlations with visual acuity and contrast sensitivity than did subjects

32 0-2 VF and 2) CS as measured by the Freiburg Visual Acuity and Contrast Test (FrACT).

33 d in multiple sclerosis patients with normal visual acuity and no history of optic neuritis.

34 ears) experienced the acute onset of reduced visual acuity and paracentral scotomas 2 weeks after the

35 ssociated with ischemia that correlated with visual acuity and radiation dose and may predict future

36 ealignment of misaligned toric IOLs improves visual acuity and reduces residual refractive errors.

37 Visual acuity and scar size were analyzed with multiple

38 Outcome measures included 3-week and 3-month visual acuity and scar size, corneal perforation, and/or

39 m for visual impairment only assesses static visual acuity and static visual field despite many Paral

40 f cone photoreceptors would preserve central visual acuity and substantially improve patients' qualit

41 Main outcome measures were change in visual acuity and the proportion of patients gaining 15

42 The UPVP performed visual acuity and undilated noncycloplegic refractive sc

43 Visual acuity and visual field impairments corresponding

44 Visual acuity and visual field were measured.

45 pressure (IOP), use of glaucoma medications, visual acuity, and complications were collected.

46 Review of culture results, visual acuity, and intraocular pressure also was perform

47 ainOutcomeMeasures: Rate of endophthalmitis, visual acuity, and microbial spectrum.

48 demonstrated that older age, poorer baseline visual acuity, and presence of retinal angiomatous proli

49 In summary, significant gains in visual acuity are seen after vitrectomy for diabetic TRD

50 The visual acuity as measured by the GoCheck Kids applicatio

51 a detailed ophthalmic examination, including visual acuity assessment and Scheimpflug imaging using t

52 Visual acuity assessment and slit-lamp biomicroscopy wer

53 yopia was assessed by a questionnaire before visual acuity assessment.

54 Mean logMAR visual acuity at presentation in cases that developed cu

55 ectable and there was partial improvement of visual acuity at the last ophthalmologic examination, 18

56 n photopic monocular best-corrected distance visual acuity (BCDVA; 4 m) and distance-corrected near v

57 th capsule complications were best-corrected visual acuity (BCVA) <=0.1 (decimal, adjusted odds ratio

58 gmatism (r = -0.09; P < 0.001), best-correct visual acuity (BCVA) (r = -0.04; P < 0.001), flat K (r =

59 8-week regimen with regard to best-corrected visual acuity (BCVA) and brolucizumab achieving greater

60 Allocation was stratified by best-corrected visual acuity (BCVA) and hospital.

61 xamination with assessment of best-corrected visual acuity (BCVA) and retinal imaging, including spec

62 plied IOP-lowering drugs, the best corrected visual acuity (BCVA) and the mean deviation (MD) of the

63 esented with light perception best-corrected visual acuity (BCVA) and tractional retinal detachment (

64 coherence tomography and the best-corrected visual acuity (BCVA) at six months.

65 The best-corrected visual acuity (BCVA) before and after surgery were compa

66 Best-corrected visual acuity (BCVA) data, retinal imaging data, and cli

67 after treatment, and a better best-corrected visual acuity (BCVA) during the first three months.

68 e interval], P value) gain in best-corrected visual acuity (BCVA) from baseline at Month 3 was 5.2 (1

69 The best-corrected visual acuity (BCVA) improvement was 0.16 LogMAR for tho

70 ularization in either eye and best-corrected visual acuity (BCVA) letter score of 49 letters or more

71 Intraocular pressure (IOP), best corrected visual acuity (BCVA) logMAR and number of glaucoma medic

72 retreatment guided by either best-corrected visual acuity (BCVA) loss (Group I) or BCVA loss and/or

73 acular degeneration (AMD) and best-corrected visual acuity (BCVA) of 20/80 to 20/800.

74 ients were required to have a best-corrected visual acuity (BCVA) of 5 or more Early Treatment Diabet

75 outcome measure was change in best corrected visual acuity (BCVA) over time.

76 Preoperative best corrected visual acuity (BCVA) showed and improvement from 0.4 +/-

77 Mean preoperative best-corrected visual acuity (BCVA) was 20/2000 (2 logarithm of the min

78 Best-corrected visual acuity (BCVA) was recorded preoperatively and, wh

79 Mean best-corrected visual acuity (BCVA) was stable; 3 implant-treated subje

80 The mean change in best-corrected visual acuity (BCVA) with IVT-AFL from baseline to 24 mo

81 endothelial cell loss (ECL), best-corrected visual acuity (BCVA), central corneal thickness (CCT), a

82 ies, ocular surgical history, best-corrected visual acuity (BCVA), intraocular pressure (IOP), clinic

83 of GA lesion from the fovea, best-corrected visual acuity (BCVA), low-luminance BCVA, and low-lumina

84 Best-corrected visual acuity (BCVA), macular sensitivity, ellipsoid zon

85 jective tests were scores for best-corrected visual acuity (BCVA); using the LogMAR scale, a multipar

86 edominantly classic CNV (mean best-corrected visual acuity [BCVA], 48.2 letters at baseline) showed a

87 Visual acuity before endophthalmitis was associated with

88 The neural circuitry that determines visual acuity begins in the retinal fovea, where the res

89 y outcomes included best spectacle-corrected visual acuity (BSCVA) at 3 weeks and 3 months, percentag

90 ection and failure, best spectacle-corrected visual acuity (BSCVA), and endothelial cell (EC) density

91 nd unfolding times, best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), a

92 recipients included best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), c

93 tcome measures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endo

94 lyses were used for best spectacle-corrected visual acuity (BSCVA), spherical equivalent, hyperopic s

95 We evaluated best spectacle-corrected visual acuity (BSCVA), topography, refraction, endotheli

96 al acuity (UDVA) or best spectacle-corrected visual acuity (BSCVA).

97 Visual acuity can be measured in many different ways, in

98 al of sutures (ROS), with corrected distance visual acuity (CDVA) >=20/40.

99 n: 35.2 +/- 22.2 months), corrected distance visual acuity (CDVA) improved in 87.7% of all eyes and r

100 ided by preoperative mean corrected distance visual acuity (CDVA) was calculated in both groups.

101 y (Pentacam), refraction, corrected distance visual acuity (CDVA), and glare CDVA was performed at 4

102 Change in corrected distance visual acuity (CDVA), severity scores of various ocular

103 ar uncorrected (UDVA) and corrected distance visual acuity (CDVA), subjective refraction, slit-lamp e

104 The following data were noted: visual acuity, central retinal thickness, distribution o

105 Visual acuity, central subfield thickness, and adverse e

106 The primary outcome was best-corrected visual acuity change (DeltaBCVA, logarithm of minimal an

107 ith visual acuity improvements and predicted visual acuity changes beyond what was explained by CST.

108 en had higher rates of astigmatism and worse visual acuity compared to all other races/ethnicities.

109 condary outcomes included corrected distance visual acuity, complications, and patient-reported outco

110 The primary outcomes measured were visual acuity, contrast and glare sensitivity (Pelli-Rob

111 were demographic profile, clinical features, visual acuity, corneal topography, aberrometry, and biom

112 an monocular distance-corrected intermediate visual acuity (DCIVA; 66 cm) and proportion of participa

113 Distance-corrected near visual acuity (DCNVA) and subjective defocus curves up t

114 ity (BCDVA; 4 m) and distance-corrected near visual acuity (DCNVA; 40 cm) at 6 months after surgery.

115 The mean best-corrected visual acuity declined by 2 lines post-PED resolution.

116 Best-corrected visual acuity decreased from 20/25 to 20/40 Snellen equi

117 asticity and promotes functional recovery of visual acuity defects from amblyopia.

118 BCVA), low-luminance BCVA, and low-luminance visual acuity deficit.

119 betes, source of referral and best-corrected visual acuity, diabetic retinopathy status in both eyes.

120 Month-1 and -3 visual acuities did not vary by pathogen-positive versus

121 (-0.05 to 0.03), and mean corrected distance visual acuity difference was -0.01 logMAR (95% confidenc

122 c exposure was not associated with decreased visual acuity, elevated intraocular pressure, or documen

123 Main outcomes measured were visual acuity, endothelial cell count (ECC), rates of se

124 e stressed in a WT animal, axon function and visual acuity equilibrate between the two projections ev

125 The visual acuity equivalent (VAE), approximate Early Treatm

126 maller pixels in future implants may improve visual acuity even further.

127 The mean preoperative best-corrected logMAR visual acuity for all patients improved from 1.2 +/- 0.8

128 To measure visual acuity for Vernier offsets, we recorded evoked po

129 ), and outperformed them in correlating with visual acuity ([Formula: see text] compared to [Formula:

130 Main outcome measures included visual acuity, Foster stages, presence of extraocular in

131 Chart review examining visual acuities from patient visits before and after sur

132 The primary outcome was a change in visual acuity from baseline at 6 months.

133 A comparison (final visual acuity, good vs. intermediate to poor) revealed a

134 Of 79 patients, 49 (62%) demonstrated good visual acuity (>=20/40) and 30 (38%) showed intermediate

135 d in 41% patients, even though final average visual acuity had improved.

136 Clinically, all patients had reduced visual acuity, hyperopia, short axial length and crowded

137 y data from clinical practice found residual visual acuity impairment among all ages and races, espec

138 Mild-to-moderate visual acuity impairments had no effect on motion cohere

139 In the entire group of 40 eyes, visual acuity improved or remained stable in 28 (70%) an

140 Visual acuity improvement after MH surgery continued dur

141 ents had a significantly lower likelihood of visual acuity improvement following intravitreal bevaciz

142 Primary study outcome was visual acuity improvement.

143 orrhage during follow-up was associated with visual acuity improvements and predicted visual acuity c

144 f corneal thickness, refraction, and (glare) visual acuity in advanced FECD.

145 SST-selective Lypd6 overexpression restores visual acuity in amblyopic mice that underwent early lon

146 e more than the right, along with decreasing visual acuity in both eyes following 3 months of PTX the

147 All had > 20/40 corrected visual acuity in each eye and were experienced field tak

148 n number of AGMs was 1 (IQR, 0-2) and median visual acuity in logarithm of minimum angle of resolutio

149 F agents are efficient treatment to maintain visual acuity in residual/recurrent DME after FAc.

150 iewed described a significant improvement in visual acuity in the binocular group versus standard pat

151 At the 6-month follow-up, median logMAR visual acuity in the cohorts with and without worsening

152 resource donation improves axon function and visual acuity in the directly stressed region, it render

153 In addition, low visual acuity in the worse eye was linked to strabismus

154 opia, astigmatism, spherical equivalent, low visual acuity in the worse seeing eye (>=1.3 logMAR), an

155 othelial cell loss, best spectacle-corrected visual acuity, intraocular pressure, and glaucoma medica

156 a complete ophthalmic examination, including visual acuity, IOP, slit lamp examination, and dilated f

157 Improving or maintaining visual acuity is the main goal for the treatment of neov

158 autorefraction, particularly when corrected visual acuity is worse than expected or the autorefracti

159 the case of foveal involvement, the loss of visual acuity lagged behind central RPE atrophy in AF im

160 Eye pain, eyelid edema, poor presenting visual acuity, larger corneal ulcer diameter, and causat

161 ated by linking them with clinical outcomes (visual acuity, lesion activity and retinal morphology) u

162 The mean visual acuity letter score over 24 weeks was 59.3 (Snell

163 The mean visual acuity letter score was 52.6 (Snellen equivalent,

164 [SD] age, 57 [11] years; 115 [56%] men; mean visual acuity letter score, 34.5 [Snellen equivalent, 20

165 ellent short-term results, with similar high visual acuity levels for both FECD and BK eyes.

166 uncorrected distance, intermediate, and near visual acuities (logarithm of the minimum angle of resol

167 cases (incidence 0.74%) of at least moderate visual acuity loss (>=15 ETDRS letters) in eyes with IOI

168 reated eyes was 1.1%, with at least moderate visual acuity loss in 0.14%.

169 d clinical measures of vision (low-luminance visual acuity, low-luminance deficit, and microperimetri

170 The VFs were excluded if visual acuity <20/400 or loss of >=2 Snellen lines from

171 40) and 30 (38%) showed intermediate to poor visual acuity (<=20/50) after PDT.

172 06 to 0.14; P = 0.386) or corrected distance visual acuity (MD, 0.01; 95% CI, -0.06 to 0.09; P = 0.73

173 2 groups when examining uncorrected distance visual acuity (MD, 0.04; 95% CI, -0.06 to 0.14; P = 0.38

174 The percentages of eyes with visual acuity measured by GoCheck Kids within 1 line of

175 was safety, and secondary outcomes included visual acuity, microperimetry and central retinal thickn

176 ted guidelines to enroll patients, including visual acuity minimums, exclusion of bilateral eyes, sam

177 After surgery, all patients had visual acuities of 20/20 to 20/25.

178 up, was achieved in 3 eyes (75%), with final visual acuities of 20/300 in 2 eyes and 20/400 in 1 eye.

179 ions adult's aged >=18 years with presenting Visual acuity of < 6/18 in the worst eye were considered

180 l quadritherapy and a best corrected Snellen visual acuity of 0.08.

181 years of age, with a baseline best-corrected visual acuity of 2.3 to -0.2 logarithm of minimal angle

182 d those eyes were more like to achieve final visual acuity of 20/20 to 20/40 (66% vs. 30%; P = 0.03),

183 d completely attached, and 42 (69%) achieved visual acuity of 20/200 or better at last follow-up.

184 f photopsia (100% vs. 0%; P = 0.04), initial visual acuity of 20/40 or better (77% vs. 23%; P < 0.001

185 of ophthalmology appointments (P = .045), a visual acuity of 20/40 or better (P = .027), and having

186 pen angle glaucoma in one or both eyes and a visual acuity of 20/40 or better in each eye.

187 Almost 30 % of all patients regained a final visual acuity of 20/40 or better, while 31.2% had poor v

188 had VI or blindness, an evaluated presenting visual acuity of 20/40 or worse in the better-seeing eye

189 gle surgery repair with a mean postoperative visual acuity of 20/47 compared with the complex group's

190 urgery success (n=39) and mean postoperative visual acuity of 20/92.

191 Those with distance visual acuity of 6/12 or worse were refracted before nea

192 Students with visual acuity of less than or equal to 6/12 in the worse

193 The median visual acuity of patients with biopsy-negative MMP at pr

194 logarithm of the minimum angle of resolution visual acuity of the whole cohort was 0.2 (0.5).

195 e no differences in gender, BMI, % body fat, visual acuity or contrast sensitivity between those with

196 ut significant improvement of best-corrected visual acuity or macular edema.

197 coherence thresholds could be measured when visual acuity or visual fields were impaired at levels c

198 Visual acuity outcomes vary; however, patients can recov

199 Visual acuity outcomes were better in eyes with no pre-e

200 lysis of similar types showed that trends in visual acuity outcomes were not inferior to those of ACI

201 es were not important factors in determining visual acuity outcomes.

202 ften requiring surgical management with poor visual acuity outcomes.

203 rs including glaucoma severity, CS, age, and visual acuity (P = .004 better eye, P = .019 worse eye).

204 Even with good central visual acuity, patients with glaucomatous macular damage

205 rt via the CISS along with distance and near visual acuities plus non-cycloplegic autorefraction usin

206 Visual acuity predicted by foveal grading was compared w

207 tral vision benefits most from the increased visual acuity provided by small pupils.

208 nalysis of IRIS Registry data and IRIS-50, a visual acuity quality measure.

209 EAA was significantly associated with worse visual acuity (r = -0.24, P = .02), but SVC and ICP EAA

210 The final Snellen visual acuity ranged from 20/20 to no light perception.

211 r 10 mum) was associated with higher odds of visual acuity recovery and maintenance (OR: 1.13; 95% CI

212 solved the CFs and contributes to impressive visual acuity recovery.

213 (CNV) can complicate AMD and lead to severe visual acuity reduction.

214 Best-corrected visual acuity remained stable in both groups.

215 Even while central visual acuity remains relatively well preserved, GA ofte

216 Visual acuity returned to baseline in only 3 of 13 eyes

217 Patients with RVO demonstrating poor initial visual acuity showed visual and anatomic benefit with an

218 on of eyes meeting target IOP, and change in visual acuity since the original trabeculectomy.

219 xamination including best corrected distance visual acuity, slit-lamp examination, in vivo confocal m

220 quency of surgical complications, changes in visual acuity, slit-lamp findings, and adverse events.

221 The median entering visual acuity (Snellen equivalent) was 20/40.

222 Visual acuity, spectral-domain (SD) OCT findings, inject

223 bullous epithelial edema, and in all cases, visual acuity stabilized or improved following discontin

224 The mean visual acuity (+/-standard deviation) improved, with 15.

225 of 6/12 or worse were refracted before near visual acuity test.

226 nts selected underwent for distance and near visual acuity test.

227 phthalmic assessment included best-corrected visual acuity testing, electrophysiologic examinations,

228 Every patient received visual acuity testing, SD-OCT and slit lamp examination

229 levation in all subjects together, while for visual acuity the parameters were r = 0.30 (p < 0.01) fo

230 ot associated with a significant decrease in visual acuity, the presence of nonexudative MNV seems to

231 e movements in the most common assessment of visual acuity, the Snellen eye chart.

232 the oxygen-induced retinopathy model reduced visual acuity thresholds, reduced electroretinography am

233 of AAK were managed medically and had stable visual acuity through their final visits (appETDRS score

234 measures were resolution of infection, final visual acuity, tolerance of miltefosine, and clinical co

235 post-operative mean of uncorrected distance visual acuity (UDVA) divided by preoperative mean correc

236 The primary outcome was unaided distance visual acuity (UDVA) in the study eye at 3 months.

237 of the visual angle) of uncorrected distance visual acuity (UDVA) or best spectacle-corrected visual

238 MainOutcomeMeasures: Uncorrected distance visual acuity (UDVA), best spectacle-corrected VA (BSCVA

239 th the impossibility of restoring acceptable visual acuity using only medical treatments.

240 Course and prognosis are benign, visual acuity usually recovers.

241 The primary outcome was mean change in visual acuity (VA [in logMAR letters]) in eyes that comp

242 Decreased visual acuity (VA) <6/12 was found in 12 of 135 eyes (8.

243 cost savings achieved by eliminating formal visual acuity (VA) and dilated fundus examinations (DFEs

244 We evaluated relationships between visual acuity (VA) and eye-related quality of life and f

245 ns between first- and second-treated eyes by visual acuity (VA) and race/ethnicity and correlations b

246 Clinical data including visual acuity (VA) and visual fields (VFs) were collated

247 Microbiologic yield and corrected visual acuity (VA) at initial presentation and last foll

248 Visual acuity (VA) at presentation with endophthalmitis

249 Postoperative assessments included visual acuity (VA) at various distances under photopic a

250 Primary end point was visual acuity (VA) change from baseline to month 12.

251 therapy intensity and its relationship with visual acuity (VA) change in real-world neovascular age-

252 The primary outcome was the change in visual acuity (VA) in the timely and delayed re-treatmen

253 Visual impairment was defined as visual acuity (VA) of > 0.3 logarithm of the minimum ang

254 contact lens (CL) vs intraocular lens (IOL), visual acuity (VA) outcome, and the need for surgery for

255 Three final outcomes were evaluated: visual acuity (VA) per eye (i.e., in the more severely a

256 ed diabetic macular edema (CI-DME) with good visual acuity (VA) represent a controversial clinical sc

257 f their disease status and to evaluate their visual acuity (VA) status.

258 e followed up until they could perform chart visual acuity (VA) testing.

259 The mean +/- SD of the best-corrected visual acuity (VA) was 0.960 +/- 0.086 decimal, (range:

260 Mean pre-endophthalmitis visual acuity (VA) was 20/64; mean VA at 6 months was 20

261 Visual acuity (VA) was analyzed annually in completers (

262 Eyes grew 4.4 mm when visual acuity (VA) was better than 20/200, and 5.2 mm wh

263 racteristics, preoperative and postoperative visual acuity (VA), and MH status.

264 ollected included the baseline demographics, visual acuity (VA), and number of intravitreal injection

265 uded the number of antiglaucoma medications, visual acuity (VA), and postoperative adverse events.

266 Secondary outcomes included visual acuity (VA), duration of symptoms before presenta

267 Demographic data, signs and symptoms, visual acuity (VA), fundus autofluorescence and OCT find

268 Visual acuity (VA), intraocular pressure (IOP) and compl

269 Visual acuity (VA), refraction, stereoacuity, strabismus

270 orrelations between the functional score and visual acuity (VA), stage of CSC, and stress were studie

271 success (SOAS) of repair, and postoperative visual acuity (VA).

272 IOP, number of IOP-lowering medications, and visual acuity (VA).

273 bilateral amblyopia patients have asymmetric visual acuity (VA).

274 RRD, surgical procedures, and best-corrected visual acuity (VA).

275 The impact of ocular (e.g., changes in visual acuity [VA], activity status, cataract surgery) a

276 Vision tests probed cones (best-corrected visual acuity [VA], contrast sensitivity), mixed cones a

277 nce of visual impairment based on presenting visual acuity value was 2.4 +/- 0.7% using the World Hea

278 The baseline mean visual acuity was 0.6 +/- 0.5 logarithm of the minimum a

279 ; Snellen equivalent, 20/80), and the 7-year visual acuity was 0.8 +/- 0.6 logMAR (Snellen equivalent

280 nal logarithm of minimal angle of resolution visual acuity was 1.2 + 1.0.

281 ing logarithm of minimal angle of resolution visual acuity was 1.7 +/- 0.8 and the average final loga

282 logarithm of minimal angle of resolution of visual acuity was 1.89 +/- 0.71.

283 Upon examination, best-corrected visual acuity was 20/100 in the right eye and counting f

284 On examination, best-corrected visual acuity was 20/20 in both eyes.

285 Best-corrected visual acuity was 20/50 or worse in 37.3% and 20/200 or

286 Visual acuity was better in the subsequent eye at presen

287 egmentation errors (SE) in the slabs and low visual acuity was established with a one-way ANOVA.

288 Visual acuity was measured 1) by GoCheck Kids mobile app

289 the proper placement of the chip, prosthetic visual acuity was only 10% to 30% less than the level ex

290 Visual acuity was significantly reduced in eyes with RRD

291 follow-up period (P < .001); best-corrected visual acuity was similar at every time point to eyes th

292 Visual acuity was taken using Snellens chart at 6 m.

293 vement in GA area, retardation of growth, or visual acuity were not demonstrated.

294 cant predictors for the worsening of DME and visual acuity when the treatment interval was extended t

295 GS were associated with worse month-1 and -3 visual acuity, whereas the S epidermidis loads did not a

296 Treatment as needed resulted in less gain in visual acuity, whether instituted at enrollment or after

297 Impaired subjective morning visual acuity with improvement of symptoms during the da

298 ondicherry, India, with fungal keratitis and visual acuity worse than 20/70 received topical natamyci

299 ual impairment refers to presenting distance visual acuity worse than 6/18 in the worst eye.

300 In 5 of 6 cases, visual acuity worsened with onset of bullous epithelial